Please enable JavaScript.
Coggle requires JavaScript to display documents.
The Future Role of Cardio-oncologists - Coggle Diagram
The Future Role of Cardio-oncologists
Generalities
There is an increasing number of patients with malignancy who have a history of CV disease or an increased CV risk
Medical, social and economic problems
Progress in the treatment of malignant diseases
Improved survival of patients
Can be limited by adverse effects associated with intensive antitumorous treatment
Cardiovascular disease and cancer remain the two most common causes of mortality
Wide Spectrum of Cardiovascular Complications
of Cancer Treatment
The first clinical manifestation of adverse effects from anticancer drugs on the CV system was depression
Myocardial dysfunction and heart failure are the most concerning CV complications
Increase in morbidity and
mortality
Diagnosis of myocardial dysfunction was based on a decrease of left ventricular ejection fraction
Potential beneficial role of cardiomarkers
Detection of early manifestation of cardiotoxicity
(troponins
and natriuretic peptides)
ECG and echocardiography focused on left ventricle function were seen to be sufficient to cover all cardiotoxicity problems
CV complications
Myocardial dysfunction and heart failur
coronary artery disease
valvular disease
arrhythmias
arterial hypertension
thromboembolic disease
peripheral vascular disease and stroke
pulmonary hypertension
pericardial complications
Basic Concept for the Management of Patients Treated with Potentially Cardiotoxic Drugs
Precise timing and frequency of imaging and/or biomarkers sampling depends on the specific cancer treatment
Total cumulative dose
Delivery protocol and the patient’s baseline CV risk profile
Treatment with angiotensin-converting enzyme inhibitors in combination with beta blockers should be considered as a prevention
Cardio-oncology Team and Cardio-oncology Subspeciality
Referred to cardiologist for further examination and CV treatmen
cancer treatment requires tight cooperation between oncologist and cardiologist in the identification of at risk patients
Planning of treatment
patient surveillance with the aim
to prevent cardiotoxicity
Detect early signs of cardiotoxicity
Take appropriate measures to solve complications
Cardio-oncology Clinic
key components for the
effective work
High level of programme leadership
Appropriate location
Experienced staff
CV testing
The cardio-oncology nurse coordinator can be a useful member of the cardio-oncology team
Education should be focused on staff
education, trainee education and community
education